Market Place
Sourcing Support
Movement in Senior Management Personnel
03 Dec 2025 //
PRESS RELEASE
Strides and Incepta Partner to Expand Women’s Health Access
17 Oct 2025 //
PRESS RELEASE
Strides Partners with Kenox to Expand Nasal Spray Portfolio in US
09 Sep 2025 //
PRESS RELEASE
Strides Pharma Science Report Q1 Fy26 Pat at Rs. 105.6 Cr
05 Aug 2025 //
INDPHARMAPOST
Strides Delivers a Strong Q1FY26 with ?11,197m Revenue
29 Jul 2025 //
PRESS RELEASE
Intimation pursuant to Regulation 31A
27 Jun 2025 //
PRESS RELEASE
Closure of Trading Window
27 Jun 2025 //
PRESS RELEASE
Divestment of a Dormant Step-down Wholly Owned Subsidiary
16 Jun 2025 //
PRESS RELEASE
Change in Senior Management Personnel
30 May 2025 //
PRESS RELEASE
Annual Secretarial Compliance Report for the year ended March 31
27 May 2025 //
PRESS RELEASE
Strides Pharma Q4 net profit rises 5x to Rs. 113 Cr
24 May 2025 //
PRESS RELEASE
Strides Pharma gets USFDA approval for Celecoxib Capsules
01 May 2025 //
PRESS RELEASE
Strides acquires identified ANDAs from Nostrum Laboratories
29 Apr 2025 //
PRESS RELEASE
Strides Incorporation of Step-down Wholly Owned Subsidiary in India
11 Apr 2025 //
PRESS RELEASE
Update on redemption of NCDs
03 Apr 2025 //
PRESS RELEASE
Strides Pharma Proposed de merger of Business of Arco Lab
19 Mar 2025 //
MARKET NEWS
Strides Pharma Dissolution of Generic Partners, UK
18 Mar 2025 //
MEDICAL DIALOUGE
Strides Pharma global to acquire 100% stake in Amextel
18 Mar 2025 //
BUSINESS STD
Strides Recognized Among Leading Global ESG Performers
05 Feb 2025 //
PRESS RELEASE
Strides reports 14.6% growth in Q3 FY25 revenue
31 Jan 2025 //
BSE INDIA
Strides Pharma jumps after OneSource set to debut on Jan 24
23 Jan 2025 //
PRESS RELEASE
Strides Pharma Scores 76/100 ESG Rating In S&P Global CSA 2024
22 Jan 2025 //
PRESS RELEASE
Strides gains FDA approval for Acetaminophen and Ibuprofen
20 Jan 2025 //
PRESS RELEASE
Strides`s Generics Acetaminophen, Ibuprofen Receives Approval in US
17 Jan 2025 //
FDA
Strides Pharma Science Ltd leads gainers in `A` group
01 Jan 2025 //
BUSINESS STD
Strides Pharma Science Ltd leads losers in `A` group
04 Dec 2024 //
BUSINESS STD
Successful completion of fund raising of USD 95 Mn by Onesource
25 Nov 2024 //
EXPRESS PHARMA
OneSource Pharma Raises Rs 801 Cr via Equity Issuance
25 Nov 2024 //
BUSINESS STD
Strides Pharma rises 4% after NCLT nods creation of OneSource
21 Nov 2024 //
BUSINESS STD
Strides Pharma jumps on securing NCLT nod for OneSource
21 Nov 2024 //
BUSINESS STD
NCLT Approval for creation OneSource India’s 1st Specialty CDMO
19 Nov 2024 //
MONEY CONTROL
India Advances Epilepsy Treatment with New Drugs & Surgical Options
16 Nov 2024 //
PHARMABIZ
Strides Pharma Reports Q2 FY25 Consolidated PAT of Rs. 93.23 Cr
28 Oct 2024 //
INDIANPHARMAPOST
Strides Pharma reports Q2 FY25 consolidated PAT at Rs. 93.23 Cr
24 Oct 2024 //
BUSINESS STD
OneSource receives equity of Rs 8,010 Mn at a pre-money equity
18 Oct 2024 //
PRESS RELEASE
OneSource unveils new brand identity at CPHI Milan
10 Oct 2024 //
INDPHARMAPOST
OneSource in talks to raise Rs 1,670 crore in pre-listing round
26 Sep 2024 //
ECONOMICTIMES
Strides Pharma subsidiary receives USFDA approval for 60 mg Fluoxetine tablets
18 Sep 2024 //
EXPRESSPHARMA
Strides secures shareholders` nod for OneSource specialty CDMO unit
11 Sep 2024 //
ECONOMICTIMES
Proxy advisors vote against Strides Pharma’s consolidation scheme
09 Sep 2024 //
ECONOMICTIMES
Strides gets USFDA nod for Theophylline extended-release tablets
07 Sep 2024 //
ECONOMICTIMES
Strides Pharma`s Generics Theophylline Receives Approval in US
05 Sep 2024 //
FDA
Strides Pharma posts Q1 FY25 PAT at Rs. 68.3 Cr
01 Aug 2024 //
PRESS RELEASE
Strides receives USFDA approval for Sucralfate OralSuspension, 1gm/10 mL
23 May 2024 //
EXPRESS PHARMA
Strides receives USFDA approval for Sevelamer Carbonate Tablets
10 May 2024 //
EXPRESS PHARMA
Strides Pharma gets USFDA nod for antidepressant medication
09 Apr 2024 //
FIRSTWORLD PHARMA
Strides receives USFDA approval for Gabapentin
05 Mar 2024 //
BUSINESS STD
Strides reports strong Q3FY24 Revenue and EBITDA
30 Jan 2024 //
BSEINDIA
Strides Pharma`s Generic Pregabalin Receives Approval in the U.S.
24 Jan 2024 //
FDA
Strides Pharma Science to invest in AMP-6, AMP-8
03 Jan 2024 //
INDIAN PHARMA POST
Strides Science extends guarantee to Trinity Pharma Proprietary’s borrowing
21 Dec 2023 //
INDIAN PHARMA POST
Strides launches Icosapent Ethyl Acid Soft Gel capsules in
02 Dec 2023 //
INDIAN PHARMA POST
Strides Pharma to sell its Singapore manufacturing facility for $15 million
27 Oct 2023 //
ENDPTS
Strides Pharma to spin off contract development unit
25 Sep 2023 //
ECONOMIC TIMES
Strides Pharma arm gets USFDA nod for generic Mycophenolate Mofetil oral sus
31 Aug 2023 //
ECONOMICTIMES
Enforcement Report - Week of July 12, 2023
12 Jul 2023 //
FDA
Strides sells arm`s manufacturing unit to Syngene International for Rs 702 crore
05 Jul 2023 //
ECONOMIC TIMES
Strides and Orbicular enter into a strategic partnership for nasal sprays
04 May 2023 //
INDIANPHARMAPOST
Strides Pharma`s Kauliv (teriparatide) Receives Approval in Europe
07 Mar 2023 //
EMA
